SOX17 and pulmonary arterial hypertension: To validate these findings in human PAH, our qPCR analysis demonstrated a significantly reduced expression of both SOX17 and Nestin, with concomitant elevated level of p16INK4a in pulmonary microvascular ECs from PAH patients versus non-diseased ECs (Fig. 3C–E).